Late appearance and exacerbation of primary Raynaud's phenomenon attacks can predict future development of connective tissue disease: a retrospective chart review of 3,035 patients.

Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies. Rheumatol Int (2015) 0.81

Uniphasic Blanching of the Fingers, Abnormal Capillaroscopy in Nonsymptomatic Digits, and Autoantibodies: Expanding Options to Increase the Level of Suspicion of Connective Tissue Diseases beyond the Classification of Raynaud's Phenomenon. J Immunol Res (2015) 0.76

Diagnosis of Raynaud's phenomenon by (99m)Tc-pertechnetate hand perfusion scintigraphy: a pilot study. Rheumatol Int (2016) 0.75

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05

The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis (2002) 20.48

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol (1988) 16.45

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum (1999) 7.67

Polymyositis and dermatomyositis (second of two parts). N Engl J Med (1975) 7.26

Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance. Arthritis Rheum (2006) 2.57

Advances in statistical methodology for the evaluation of diagnostic and laboratory tests. Stat Med (1994) 2.45

Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol (1989) 1.99

Raynaud's phenomenon: a proposal for classification. Clin Exp Rheumatol (1993) 1.96

Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum (2008) 1.74

Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol (1999) 1.68

Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies. Ann Rheum Dis (1982) 1.39

Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med (1998) 1.29

The clinical significance of Raynaud's syndrome. Surgery (1976) 1.25

Prevalence of symptoms of Raynaud's phenomenon in general practice. BMJ (1990) 1.20

Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud's phenomenon. J Rheumatol (1982) 1.20

Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire. J Chronic Dis (1986) 1.20

Predictive value of nailfold capillaroscopy in patients with Raynaud's phenomenon. Clin Rheumatol (2005) 1.06

Scleroderma overlap syndrome. Isr Med Assoc J (2011) 1.03

The occurrence of Raynaud's phenomenon in a general population: the Framingham Study. Vasc Med (1997) 0.99

Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud's phenomenon. Rheumatol Int (2011) 0.98

Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: role of autoantibodies and nail-fold capillaroscopy. Rheumatology (Oxford) (2010) 0.97

Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison. J Rheumatol (1997) 0.96

Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (prognostic index for nailfold capillaroscopic examination). Arthritis Rheum (2008) 0.93

Early detection of connective tissue disease in patients with Raynaud's phenomenon. Rheum Dis Clin North Am (1990) 0.89

The potential of ESSG spondyloarthropathy classification criteria as a diagnostic aid in rheumatological practice. J Rheumatol (2002) 0.87

Raynaud's phenomenon. Rheum Dis Clin North Am (1996) 0.84

Raynaud's phenomenon as an early sign of connective tissue diseases. Vasa Suppl (1992) 0.80

The predictive value of quantitative nailfold capillary microscopy in patients with undifferentiated connective tissue disease. Br J Dermatol (1998) 0.75

Connective tissue disease in patients presenting with Raynaud's phenomenon alone. Ann Rheum Dis (1991) 0.75

Mechanisms of aortic blunt rupture in fatally injured front-seat passengers in frontal car collisions: an autopsy study. Am J Forensic Med Pathol (2006) 1.51

Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud's phenomenon. Rheumatol Int (2011) 0.98

Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in rheumatoid arthritis. J Rheumatol (2011) 0.91

A randomized, double-blind, placebo-controlled, twelve-week, dose-ranging study of decernotinib, an oral selective JAK-3 inhibitor, as monotherapy in patients with active rheumatoid arthritis. Arthritis Rheumatol (2015) 0.90

Comethylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic value. World J Gastroenterol (2007) 0.86

Diagnostic value of salivary gland ultrasonographic scoring system in primary Sjogren's syndrome: a comparison with scintigraphy and biopsy. J Rheumatol (2009) 0.83

Is there a difference in systemic lupus erythematosus with and without Raynaud's phenomenon? Rheumatol Int (2012) 0.80

Psoriatic arthritis criteria evaluation: CASPAR and Modified CASPAR. Clin Exp Rheumatol (2011) 0.78

Psoriatic arthritis classification criteria: Moll and Wright, ESSG and CASPAR -- a comparative study. Acta Reumatol Port (2013) 0.76

Lower extremity lipedema, upper extremity lipodystrophy and severe calcinosis complicating juvenile dermatomyositis. Rheumatol Int (2014) 0.75

Amount of postmortem bleeding: an experimental autopsy study. Am J Forensic Med Pathol (2004) 0.75

Pontomedullary lacerations in pedestrians: an autopsy study. Med Sci Law (2012) 0.75

Activity and expression of dipeptidyl peptidase IV on peripheral blood mononuclear cells in patients with early steroid and disease modifying antirheumatic drugs naïve rheumatoid arthritis. Clin Chem Lab Med (2017) 0.75

The value of pattern capillary changes and antibodies to predict the development of systemic sclerosis in patients with primary Raynaud's phenomenon. Rheumatol Int (2013) 0.75

Effect of short-term exercise training in patients following acute myocardial infarction treated with primary percutaneous coronary intervention. Eur J Phys Rehabil Med (2016) 0.75

Molecular Mechanisms of Posttraumatic Stress Disorder (PTSD) as a Basis for Individualized and Personalized Therapy: Rationale, Design and Methods of the South Eastern Europe (SEE)-PTSD study. Psychiatr Danub (2016) 0.75